Filing Details
- Accession Number:
- 0001209191-10-030312
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-25 13:00:00
- Reporting Period:
- 2010-05-21
- Filing Date:
- 2010-05-25
- Accepted Time:
- 2010-05-25 16:58:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
887359 | Aastrom Biosciences Inc | ASTM | Biological Products, (No Disgnostic Substances) (2836) | 943096597 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1242613 | M Timothy Mayleben | Po Box 376 Ann Arbor MI 48106 | Ceo, President, Cfo & Director | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-05-21 | 17,600 | $1.42 | 52,418 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Reflects a 1-for-8 reverse stock split which became effective on February 18, 2010.